# Crescent Energy Co: financial statements, quarterly

CRGY · NYSE · CIK 1866175 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crgy.md) · [Financials](/companies/crgy/financials.md) · [Filings](/companies/crgy/filings.md) · [Insiders](/companies/crgy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crgy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [642](/filings/0001866175-24-000106.md) | [658 d](/filings/0001866175-26-000026.md) | [657](/filings/0001866175-25-000078.md) | [653](/filings/0001866175-25-000109.md) | [745](/filings/0001866175-25-000167.md) | [875 d](/filings/0001866175-26-000026.md) | [950](/filings/0001866175-26-000090.md) | [898](/filings/0001866175-26-000114.md) | [867](/filings/0001866175-25-000167.md) | [865 d](/filings/0001866175-26-000026.md) | [1,183](/filings/0001866175-26-000090.md) | [1,395](/filings/0001866175-26-000114.md) |
| Operating income | $m | [142](/filings/0001866175-24-000106.md) | [(31.4) d](/filings/0001866175-26-000026.md) | [134](/filings/0001866175-25-000078.md) | [119](/filings/0001866175-25-000109.md) | [(7.4)](/filings/0001866175-25-000167.md) | [(27.5) d](/filings/0001866175-26-000026.md) | [172](/filings/0001866175-26-000090.md) | [79.6](/filings/0001866175-26-000114.md) | [30.8](/filings/0001866175-25-000167.md) | [(53.4) d](/filings/0001866175-26-000026.md) | [327](/filings/0001866175-26-000090.md) | [581](/filings/0001866175-26-000114.md) |
| Interest expense | $m | [42.2](/filings/0001866175-23-000073.md) | [43.2 d](/filings/0001866175-24-000015.md) | [42.7](/filings/0001866175-24-000053.md) | [42.4](/filings/0001866175-25-000109.md) | [61.8](/filings/0001866175-25-000167.md) | [69.4 d](/filings/0001866175-26-000026.md) | [73.2](/filings/0001866175-26-000090.md) | [75.2](/filings/0001866175-26-000114.md) | [72.6](/filings/0001866175-25-000167.md) | [77.4 d](/filings/0001866175-26-000026.md) | [105](/filings/0001866175-26-000090.md) | [99.8](/filings/0001866175-26-000114.md) |
| Income tax | $m | [(20.6)](/filings/0001866175-24-000106.md) | [18.3 d](/filings/0001866175-26-000026.md) | [(4.2)](/filings/0001866175-25-000078.md) | [11.5](/filings/0001866175-25-000109.md) | [(1.6)](/filings/0001866175-25-000167.md) | [(36.8) d](/filings/0001866175-26-000026.md) | [2.6](/filings/0001866175-26-000090.md) | [41.1](/filings/0001866175-26-000114.md) | [(4.0)](/filings/0001866175-25-000167.md) | [(5.1) d](/filings/0001866175-26-000026.md) | [(82.3)](/filings/0001866175-26-000090.md) | [170](/filings/0001866175-26-000114.md) |
| Net income | $m | [(52.9)](/filings/0001866175-24-000106.md) | [55.5 d](/filings/0001866175-26-000026.md) | [(24.2)](/filings/0001866175-25-000078.md) | [37.5](/filings/0001866175-25-000109.md) | [(9.9)](/filings/0001866175-25-000167.md) | [(118) d](/filings/0001866175-26-000026.md) | [(2.2)](/filings/0001866175-26-000090.md) | [153](/filings/0001866175-26-000114.md) | [(9.5)](/filings/0001866175-25-000167.md) | [(8.7) d](/filings/0001866175-26-000026.md) | [(420)](/filings/0001866175-26-000090.md) | [493](/filings/0001866175-26-000114.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001866175-24-000106.md) | [0.0](/filings/0001866175-26-000026.md) | [0.0](/filings/0001866175-25-000078.md) | [0.8](/filings/0001866175-25-000109.md) | [0.1](/filings/0001866175-25-000167.md) | [0.1](/filings/0001866175-26-000026.md) | [0.0](/filings/0001866175-26-000090.md) | [0.0](/filings/0001866175-26-000114.md) | [0.0](/filings/0001866175-25-000167.md) | [0.0](/filings/0001866175-26-000114.md) | [0.0](/filings/0001866175-26-000090.md) | [0.3](/filings/0001866175-26-000114.md) |
| Current assets | $bn | [0.9](/filings/0001866175-23-000073.md) | [0.6](/filings/0001866175-25-000024.md) | [0.6](/filings/0001866175-24-000053.md) | [1.3](/filings/0001866175-24-000071.md) | [0.9](/filings/0001866175-24-000106.md) | [0.8](/filings/0001866175-26-000026.md) | [0.7](/filings/0001866175-25-000078.md) | [0.8](/filings/0001866175-25-000109.md) | [0.7](/filings/0001866175-25-000167.md) | [1.9](/filings/0001866175-26-000114.md) | [0.9](/filings/0001866175-26-000090.md) | [1.1](/filings/0001866175-26-000114.md) |
| Total assets | $bn | [7.0](/filings/0001866175-23-000073.md) | [6.8](/filings/0001866175-25-000024.md) | [6.8](/filings/0001866175-24-000053.md) | [7.5](/filings/0001866175-24-000071.md) | [9.3](/filings/0001866175-24-000106.md) | [9.2](/filings/0001866175-26-000026.md) | [9.9](/filings/0001866175-25-000078.md) | [9.9](/filings/0001866175-25-000109.md) | [9.7](/filings/0001866175-25-000167.md) | [12.4](/filings/0001866175-26-000114.md) | [12.0](/filings/0001866175-26-000090.md) | [12.0](/filings/0001866175-26-000114.md) |
| Current liabilities | $bn | [0.9](/filings/0001866175-23-000073.md) | [0.8](/filings/0001866175-25-000024.md) | [0.7](/filings/0001866175-24-000053.md) | [0.7](/filings/0001866175-24-000071.md) | [0.9](/filings/0001866175-24-000106.md) | [0.8](/filings/0001866175-26-000026.md) | [0.9](/filings/0001866175-25-000078.md) | [0.9](/filings/0001866175-25-000109.md) | [0.9](/filings/0001866175-25-000167.md) | [1.3](/filings/0001866175-26-000114.md) | [1.6](/filings/0001866175-26-000090.md) | [1.2](/filings/0001866175-26-000114.md) |
| Total liabilities | $bn | [3.5](/filings/0001866175-23-000073.md) | [3.2](/filings/0001866175-25-000024.md) | [3.3](/filings/0001866175-24-000053.md) | [3.9](/filings/0001866175-24-000071.md) | [5.1](/filings/0001866175-24-000106.md) | [4.8](/filings/0001866175-26-000026.md) | [5.4](/filings/0001866175-25-000078.md) | [5.4](/filings/0001866175-25-000109.md) | [5.2](/filings/0001866175-25-000167.md) | [7.3](/filings/0001866175-26-000114.md) | [7.3](/filings/0001866175-26-000090.md) | [6.8](/filings/0001866175-26-000114.md) |
| Long-term debt | $bn | [1.9](/filings/0001866175-23-000073.md) | [1.7](/filings/0001866175-25-000024.md) | [1.7](/filings/0001866175-24-000053.md) | [2.4](/filings/0001866175-24-000071.md) | [3.2](/filings/0001866175-24-000106.md) | [3.0](/filings/0001866175-26-000026.md) | [3.6](/filings/0001866175-25-000078.md) | [3.4](/filings/0001866175-25-000109.md) | [3.2](/filings/0001866175-25-000167.md) | [5.5](/filings/0001866175-26-000114.md) | [5.2](/filings/0001866175-26-000090.md) | [5.2](/filings/0001866175-26-000114.md) |
| Shareholders' equity | $bn | [1.6](/filings/0001866175-24-000106.md) | [1.7](/filings/0001866175-26-000026.md) | [2.0](/filings/0001866175-25-000167.md) | [2.1](/filings/0001866175-25-000167.md) | [2.9](/filings/0001866175-25-000167.md) | [3.1](/filings/0001866175-26-000114.md) | [3.3](/filings/0001866175-26-000114.md) | [4.5](/filings/0001866175-26-000114.md) | [4.5](/filings/0001866175-25-000167.md) | [5.2](/filings/0001866175-26-000114.md) | [4.7](/filings/0001866175-26-000114.md) | [5.2](/filings/0001866175-26-000114.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [189 d](/filings/0001866175-24-000106.md) | [323 d](/filings/0001866175-26-000026.md) | [184](/filings/0001866175-25-000078.md) | [287 d](/filings/0001866175-25-000109.md) | [368 d](/filings/0001866175-25-000167.md) | [384 d](/filings/0001866175-26-000026.md) | [337](/filings/0001866175-26-000090.md) | [499 d](/filings/0001866175-26-000114.md) | [473 d](/filings/0001866175-25-000167.md) | [371 d](/filings/0001866175-26-000026.md) | [409](/filings/0001866175-26-000090.md) | [707 d](/filings/0001866175-26-000114.md) |
| Dividends paid | $m | [9.1 d](/filings/0001866175-24-000106.md) | [11.0 d](/filings/0001866175-26-000026.md) | [12.6](/filings/0001866175-25-000078.md) | [13.4 d](/filings/0001866175-25-000109.md) | [19.6 d](/filings/0001866175-25-000167.md) | [19.5 d](/filings/0001866175-26-000026.md) | [23.5](/filings/0001866175-26-000090.md) | [30.6 d](/filings/0001866175-26-000114.md) | [30.6 d](/filings/0001866175-25-000167.md) | [30.6 d](/filings/0001866175-26-000026.md) | [39.3](/filings/0001866175-26-000090.md) | [39.6 d](/filings/0001866175-26-000114.md) |
| Share repurchases | $m | [(0.1) d](/filings/0001866175-24-000106.md) | [0.0 d](/filings/0001866175-26-000026.md) | [0.0](/filings/0001866175-25-000078.md) | [0.0 d](/filings/0001866175-25-000109.md) | [7.3 d](/filings/0001866175-25-000167.md) | [0.5 d](/filings/0001866175-26-000026.md) | [5.3](/filings/0001866175-26-000090.md) | [28.5 d](/filings/0001866175-26-000114.md) | [0.0 d](/filings/0001866175-25-000167.md) | [(0.4) d](/filings/0001866175-26-000026.md) | [0.0](/filings/0001866175-26-000090.md) | [0.0 d](/filings/0001866175-26-000114.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 330,403,696 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001866175-26-000114.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.